 The application of TIMPs as therapeutic instrument through gene therapy or direct protein application is still in early stages of development.It is preferable to inhibit specific MPPs that play a role in pathological conditions.Since TIMPs inhibit multiple MMPs it is desirable to develop engineered TIMPs with altered specificity.